High-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage-Part II.

Completed

Phase N/A Results

Summary of Purpose

To assess the effects of high-dose tirlazad mesylate following subarachnoid hemorrhage (SAH) in women.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 13 August 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Pharamacia-Upjohn, Inc., Kalamazoo, MI

Trial Design

Prospective randomized, double-blind, vehicle-controlled trial of 832 patients at 65 North American centers.

Contacts

Not available